Cytokinetics Insider Sold Shares Worth $490,950, According to a Recent SEC Filing

MT newswire2026/09/28 20:58

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

04:58 PM EDT, 09/28/2026 (MT Newswires) -- Robert I Blum, Director, President & CEO, on September 28, 2026, sold 7,500 shares in Cytokinetics (CYTK) for $490,950. Following the Form 4 filing with the SEC, Blum has control over a total of 282,710 common shares of the company, with 278,544 shares held directly and 4,166 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1061983/000106198326000097/xslF345X05/form4.xml

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

U.S. Treasury Secretary Janet Yellen defended the rise in U.S. Treasury yields, stating that this increase is a global phenomenon rather than unique to the United States, and does not warrant excessive concern. She partially attributed inflationary pressures to higher oil prices caused by the Iran conflict, and expects the energy shock to subside as hostilities ease. Yellen refuted the notion of an AI bubble, arguing that investments by major tech companies are grounded in solid business logic.

华尔街见闻•2026/10/04 03:06